The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients

Scandinavian Journal of Rheumatology

Volumn 36, Issue 3, 2007, Pages 167-171

  Sliwinska Stanczyk, P ^a   Pazdur, J ^a   Ziolkowska, M ^a   Jaworski, J ^a   Kaminska Tchorzewska, E ^a   Lacki, J K ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METHYLPREDNISOLONE; MIDDLE AGED;

EID: 34547448240     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740601154111     Document Type: Article

References (33)

1. Hench P, Kendall SC, Slocumb CH, Polley HF. The effects of the hormone of the adrenal cortex and of pituitary adreno-corticotropic hormone on rheumatoid arthritis. Proc Mayo Clin 1949;24:181-3.
2. van Schaardenburg D, Valkema R, Dijkmans BA, Papapoulos S, Zwinderman AH, Han KH, et al. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995;38:334-42.
3. Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, et al. Apoptosis in lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:823-30.
4. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2005;115:466-9.
5. Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid resistant ulcerative colitis. Gastroenterology 2000;118:859-66.
6. Goulding NJ, Podgorski MR, Hall ND, Flower RJ, Browning JL, et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989;48:843-50.
7. Druilhe A, Letuve S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanism of action. Apoptosis 2003;8:481-95.
8. Raddatz D, Middel P, Bockemuhl M, Benohr P, Wissmann C, Schworer H, et al. Glucocorticoid receptor expression in inflammatory bowel disease: evidence for mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther 2004;19:47-61.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
11. Schwartz HJ, Lowell FC, Melby JC. Steroid resistance in bronchial asthma. Ann Intern Med 1968;69:493-9.
12. Hirara F, Del Carmine R, Nelson CA. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin in patients with rheumatic diseases. Proc Natl Acad Sci USA 1981;78:3190-4.
13. Kay AB, Diaz P, Carmichael J, Grant IWB. Corticosteroid resistant chronic asthma and monocyte complement receptors. Clin Exp Immunol 1981;44:576-80.
14. Takahashi E, Onda K, Hirano T, Oka K, Maruoka N, Tsuyuguchi M, et al. Expression c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma. Int Immunopharmacol 2002;10:1419-27.
15. Chicanza IC. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 2002;966:36-48.
16. Adcock M, Lane SJ, Lee TH, Barnes PJ. AP-1 and glucocorticoid receptor DNA binding in peripheral blood mononuclear cells from steroid sensitive and resistant patients. Am J Respir Crit Care Med 1995;151:A391-4.
17. Buttgereit F, Saag KG, Cutolo M, da Silva JAP, Bijlsma JWJ. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 2005;34:14-21.
18. Tohyama CT, Yamakawa M, Murasawa A, Nakazono K, Ishikawa H. Localization of human glucocorticoid receptor in rheumatoid synovial tissue of the knee joint. Scand J Rheumatol 2005;34:426-32.
19. Dilger K, Cascorbi I, Grunhage F, Hohenester S, Sauerbruch T, Beuers U. Multidrug resistance 1 genotype and disposition of budesonide in early primary bilary cirrhosis. Liver Int 2006;26:285-290.
20. Pelletier J-P, Dibattista JA, Ranger P, Martel-Pelletier J. The reduced expression of glucocorticoid receptors in synovial cells induced by nonsteroidal antiinflammatory drugs can be reversed by prostaglandin E1 analog. J Rheumatol 1994;21:1748-52.
21. Uribe M, Casian C, Rojas S, Sierra JG, Go VLW. Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers. Gastroenterology 1981;80:661-5.
22. Picard D, Yamamoto KR. Two signals mediate hormone dependent nuclear localisation of the glucocorticoid receptor. EMBO J 1987;6:3333-40.
23. Frey FJ, Horber FF, Frey BM. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism. Clin Pharmacol Ther 1988;44:510-21.
24. Barnes PJ, Grening AP, Crompton GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995;152:S125-40.
25. Harris ED, Emkey RD, Nichols JE. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10:713-21.
26. Lacki JK, Leszczynski P, Mackiewicz SH. Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis. The effect on lymphocytes. J Invest Allergy Clin Immunol 1996;6:232-6.
27. Mc Dougall R, Sibley J, Haga M, Russell A. Outcome in patients with rheumatoid arthritis receiving prednisolone compared to matched controls. J Rheumatol 1994;21:1207-13.
28. van Gestel AM, Laan RFM, Haagsma CJ, van de Putte LBA, van Riel PLCM. Oral steroid as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double blind placebo controlled trial. Br J Rheumatol 1995;34:347-51.
29. Sauer J, Polack E, Wikinski S, Holsboer F, Stalla GK, Arzt E. The glucocorticoid sensitivity of lymphocytes changes according to the activity of the hypothalamic-pituitary-adrenocortical system. Psychoneuroendocrinology 1995;20:269-80.
30. Schlaghecke R, Beuscher D, Kornely E, Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 1994;37:1127-31.
31. Messner RP. Clinical aspects of T- and B-lymphocytes in rheumatic diseases. Arthritis Rheum 1974;17:339-46.
32. Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Resp Dis 1991;144:1026-32.
33. Poznansky MC, Gordon AC, Douglas JG, Krajewski AS, Wyllie AH, Grant IW. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci 1984;67:639-45.